STING1 and COVID-19: Accordingly, the outcome of rheumatoid arthritis with severe COVID-19 treated or not by methotrexate or sulfasalazine could be worth to study, although methotrexate as only limited efficacy against SAVI (STING-associated vasculopathy with onset in infancy) syndromes.